Biopharmaceutical studies on guaiacol glyceryl ether and related compounds. V.
D000085:Acetates / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001702:Biopharmaceutics; D002196:Capillaries / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism; D002850:Chromatography, Gel; D004347:Drug Interactions; D005374:Filtration; D006140:Guaifenesin / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D006168:Guinea Pigs; D006591:Hexobarbital / Q000097:blood / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000032:analysis; D051379:Mice; D008815:Mice, Inbred Strains; D009539:Nicotinic Acids / Q000097:blood / Q000494:pharmacology / Q000652:urine; D010539:Permeability; D051381:Rats; D011919:Rats, Inbred Strains; D012018:Reflex / Q000187:drug effects; D012890:Sleep / Q000187:drug effects
D000085:Acetates; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D009539:Nicotinic Acids; D006140:Guaifenesin; D002784:Cholesterol; D006591:Hexobarbital